Table of Contents

• Janet B. McGill,
• Thomas G. Cole,
• William Nowatzke,
• Shannon Houghton,
• Erika B. Ammirati,
• Theresa Gautille,
• and Mark J. Sarno

Circulating 1,5-Anhydroglucitol Levels in Adult Patients With Diabetes Reflect Longitudinal Changes of Glycemia: A U.S. trial of the GlycoMark assay

• Salwa W. Rizkalla,
• Laika Taghrid,
• Muriel Laromiguiere,
• Dorothée Huet,
• Josette Boillot,
• Aude Rigoir,
• Fabienne Elgrably,
• and Gerard Slama

Improved Plasma Glucose Control, Whole-Body Glucose Utilization, and Lipid Profile on a Low-Glycemic Index Diet in Type 2 Diabetic Men: A randomized controlled trial

• Guillermo E. Umpierrez,
• Ruben Cuervo,
• Ana Karabell,
• Kashif Latif,
• Amado X. Freire,
• and Abbas E. Kitabchi

Treatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart

• Gregory A. Nichols,
• Christina M. Gullion,
• Carol E. Koro,
• Sara A. Ephross,
• and Jonathan B. Brown

The Incidence of Congestive Heart Failure in Type 2 Diabetes: An update

• Helaine E. Resnick,
• Elizabeth A. Carter,
• Jay M. Sosenko,
• Susan J. Henly,
• Richard R. Fabsitz,
• Frederick K. Ness,
• Thomas K. Welty,
• Elisa T. Lee,
• and Barbara V. Howard

Incidence of Lower-Extremity Amputation in American Indians: The Strong Heart Study

• Gerry Rayman,
• Singhan T.M. Krishnan,
• Neil R. Baker,
• Alison M. Wareham,
• and Anne Rayman

Are We Underestimating Diabetes-Related Lower-Extremity Amputation Rates?: Results and benefits of the first prospective study

• Andrew J. Palmer,
• Lieven Annemans,
• Stéphane Roze,
• Mark Lamotte,
• Pablo Lapuerta,
• Roland Chen,
• Sylvie Gabriel,
• Paulo Carita,
• Roger A. Rodby,
• Dick de Zeeuw,
• and Hans-Henrik Parving

Cost-Effectiveness of Early Irbesartan Treatment Versus Control (Standard Antihypertensive Medications Excluding ACE Inhibitors, Other Angiotensin-2 Receptor Antagonists, and Dihydropyridine Calcium Channel Blockers) or Late Irbesartan Treatment in Patients With Type 2 Diabetes, Hypertension, and Renal Disease

• Gabriel Olveira-Fuster,
• Pilar Olvera-Márquez,
• Florentino Carral-Sanlaureano,
• Stella González-Romero,
• Manuel Aguilar-Diosdado,
• and Federico Soriguer-Escofet

Excess Hospitalizations, Hospital Days, and Inpatient Costs Among People With Diabetes in Andalusia, Spain

• Mette Zander,
• Allan Christiansen,
• Sten Madsbad,
• and Jens Juul Holst

Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes

• Helle Harder,
• Lene Nielsen,
• Tu D.T. Thi,
• and Arne Astrup

The Effect of Liraglutide, a Long-Acting Glucagon-Like Peptide 1 Derivative, on Glycemic Control, Body Composition, and 24-h Energy Expenditure in Patients With Type 2 Diabetes

• Boris P. Kovatchev,
• Linda A. Gonder-Frederick,
• Daniel J. Cox,
• and William L. Clarke

Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors: Continuous glucose–error grid analysis illustrated by TheraSense Freestyle Navigator data

• Martin Magnusson,
• Olle Melander,
• Bo Israelsson,
• Anders Grubb,
• Leif Groop,
• and Stefan Jovinge

Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease

• Shoichiro Tanaka,
• Toyoshi Endo,
• Kaoru Aida,
• Hiroki Shimura,
• Norihiko Yokomori,
• Masahiro Kaneshige,
• Fumihiko Furuya,
• Shin Amemiya,
• Mie Mochizuki,
• Koji Nakanishi,
• and Tetsuro Kobayashi

Distinct Diagnostic Criteria of Fulminant Type 1 Diabetes Based on Serum C-Peptide Response and HbA_1c Levels at Onset

• Gerhard Pichler,
• Berndt Urlesberger,
• Paul Jirak,
• Heinz Zotter,
• Elke Reiterer,
• Wilhelm Müller,
• and Martin Borkenstein

Reduced Forearm Blood Flow in Children and Adolescents With Type 1 Diabetes (Measured by Near-Infrared Spectroscopy)

• Bert E. Suys,
• Nienke Katier,
• Raoul P.A. Rooman,
• Dirk Matthys,
• Lieve Op De Beeck,
• Mark V.L. Du Caju,
• and Daniel De Wolf

Female Children and Adolescents With Type 1 Diabetes Have More Pronounced Early Echocardiographic Signs of Diabetic Cardiomyopathy

• Frans J.Th. Wackers,
• Lawrence H. Young,
• Silvio E. Inzucchi,
• Deborah A. Chyun,
• Janice A. Davey,
• Eugene J. Barrett,
• Raymond Taillefer,
• Steven D. Wittlin,
• Gary V. Heller,
• Neil Filipchuk,
• Samuel Engel,
• Robert E. Ratner,
• and Ami E. Iskandrian

Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects: The DIAD study

• Mohan Rema,
• Viswanathan Mohan,
• Raj Deepa,
• and Radhakrishnan Ravikumar

Association of Carotid Intima-Media Thickness and Arterial Stiffness With Diabetic Retinopathy: The Chennai Urban Rural Epidemiology Study (CURES-2)

• Steven C. Elbein and
• Mohammad A. Karim

Does the Aspartic Acid to Asparagine Substitution at Position 76 in the Pancreas Duodenum Homeobox Gene (PDX1) Cause Late-Onset Type 2 Diabetes?

• Gary L. Pittenger,
• Madhumita Ray,
• Niculina I. Burcus,
• Patricia McNulty,
• Baher Basta,
• and Aaron I. Vinik

Intraepidermal Nerve Fibers Are Indicators of Small-Fiber Neuropathy in Both Diabetic and Nondiabetic Patients

• David G. Armstrong,
• Lawrence A. Lavery,
• Katherine Holtz-Neiderer,
• Martha J. Mohler,
• Christopher S. Wendel,
• Brent P. Nixon,
• and Andrew J.M. Boulton

Variability in Activity May Precede Diabetic Foot Ulceration

• Jeffrey P. Krischer,
• David D. Cuthbertson,
• and Carla Greenbaum

Male Sex Increases the Risk of Autoimmunity but not Type 1 Diabetes

• Rui Jiang,
• Matthias B. Schulze,
• Tricia Li,
• Nader Rifai,
• Meir J. Stampfer,
• Eric B. Rimm,
• and Frank B. Hu

Non-HDL Cholesterol and Apolipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes

• Sun H. Kim,
• Fahim Abbasi,
• and Gerald M. Reaven

Impact of Degree of Obesity on Surrogate Estimates of Insulin Resistance

• Casey J.A. Smith,
• Patricia A. Crock,
• Bruce R. King,
• Cliff J. Meldrum,
• and Rodney J. Scott

Phenotype-Genotype Correlations in a Series of Wolfram Syndrome Families

• Alba Morales,
• Clive Wasserfall,
• Todd Brusko,
• Carolyn Carter,
• Desmond Schatz,
• Janet Silverstein,
• Tamir Ellis,
• and Mark Atkinson

Adiponectin and Leptin Concentrations May Aid in Discriminating Disease Forms in Children and Adolescents With Type 1 and Type 2 Diabetes

• Simonetta Bacci,
• Claudia Menzaghi,
• Tonino Ercolino,
• Xiaowei Ma,
• Anna Rauseo,
• Lucia Salvemini,
• Carlo Vigna,
• Raffaele Fanelli,
• Umberto Di Mario,
• Alessandro Doria,
• and Vincenzo Trischitta

The +276 G/T Single Nucleotide Polymorphism of the Adiponectin Gene Is Associated With Coronary Artery Disease in Type 2 Diabetic Patients

• Katariina Sivenius,
• Jussi Pihlajamäki,
• Juhani Partanen,
• Leo Niskanen,
• Markku Laakso,
• and Matti Uusitupa

Aldose Reductase Gene Polymorphisms and Peripheral Nerve Function in Patients With Type 2 Diabetes

• Jee-Young Oh,
• Young Sun Hong,
• Yeon-Ah Sung,
• and Elizabeth Barrett-Connor

Prevalence and Factor Analysis of Metabolic Syndrome in an Urban Korean Population

• Adamandia D. Kriketos,
• Jerry R. Greenfield,
• Phil W. Peake,
• Stuart M. Furler,
• Gareth S. Denyer,
• John A. Charlesworth,
• and Lesley V. Campbell

Inflammation, Insulin Resistance, and Adiposity: A study of first-degree relatives of type 2 diabetic subjects

• Ulf Risérus,
• Johan Ärnlöv,
• Kerstin Brismar,
• Björn Zethelius,
• Lars Berglund,
• and Bengt Vessby

Sagittal Abdominal Diameter Is a Strong Anthropometric Marker of Insulin Resistance and Hyperproinsulinemia in Obese Men

• James D. Lane,
• Christina E. Barkauskas,
• Richard S. Surwit,
• and Mark N. Feinglos

Caffeine Impairs Glucose Metabolism in Type 2 Diabetes

• Muzahir H. Tayebjee,
• H. Sern Lim,
• Robert J. MacFadyen,
• and Gregory Y.H. Lip

Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes: Effect of 1 year’s cardiovascular risk reduction therapy

• Franco Cavalot,
• Katia Bonomo,
• Paolo Perna,
• Elisa Bacillo,
• Paola Salacone,
• Monica Gallo,
• Luigi Mattiello,
• Mariella Trovati,
• and Ezio Gaia

Pancreatic Elastase-1 in Stools, a Marker of Exocrine Pancreas Function, Correlates With Both Residual β-Cell Secretion and Metabolic Control in Type 1 Diabetic Subjects

• Antonino Coppola,
• Costantino Astarita,
• Michele Oliviero,
• Dario Fontana,
• Giuseppe Picardi,
• Katherine Esposito,
• Raffaele Marfella,
• Ludovico Coppola,
• and Dario Giugliano

Impairment of Coronary Circulation by Acute Hyperhomocysteinemia in Type 2 Diabetic Patients

• Jesús Medina,
• Luis I. Fernández-Salazar,
• Luisa García-Buey,
• and Ricardo Moreno-Otero

Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis

• Samuel Klein,
• Nancy F. Sheard,
• Xavier Pi-Sunyer,
• Anne Daly,
• Judith Wylie-Rosett,
• Karmeen Kulkarni,
• and Nathaniel G. Clark

Weight Management Through Lifestyle Modification for the Prevention and Management of Type 2 Diabetes: Rationale and Strategies: A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition

• Zachary T. Bloomgarden

Inpatient Diabetes Control: Rationale

• Lawrence H. Young

Diastolic Function and Type 1 Diabetes

• Yuichi Nishi,
• Hiroyuki Koshiyama,
• Sachiko Honjo,
• and Yutaka Seino

Poor Correlation of Pulse-Wave Velocity and Intima-Media Thickness in Diabetic Subjects

• Xu JiXiong,
• Liu Jianying,
• Chang Yulan,
• and Chen Huixian

The Human Insulin Analog Aspart Can Induce Insulin Allergy

• Giovanni Targher,
• Lorenzo Bertolini,
• and Luciano Zenari

Hypoadiponectinemia Is Closely Associated With Nonalcoholic Hepatic Steatosis in Obese Subjects

• Richard I.G. Holt

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement

• Leslie Citrome and
• Jan Volavka

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement

• Michael T. Isaac and
• Maria B. Isaac

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement

• Gerard Boehm,
• Judith A. Racoosin,
• Thomas P. Laughren,
• and Russell Katz

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement

• Eugene J. Barrett

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to Holt, Citrome and Volevka, Isaac and Isaac, and Boehm et al.

• John L. Kitzmiller

Randomized Trial Evaluating a Predominately Fetal Growth–Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women: Response to Schaefer-Graf et al.

• Ute M. Schaefer-Graf

Randomized Trial Evaluating a Predominately Fetal Growth–Based Strategy to Guide Management of Gestational Diabetes in Caucasian Women: Response to Kitzmiller

• Anastasia C. Thanopoulou,
• Basil G. Karamanos,
• and Demetra P. Roussi

A Standardized Triglyceride and Carbohydrate Challenge: Response to Mohanlal and Holman

• Nina Mohanlal and
• Rury R. Holman

A Standardized Triglyceride and Carbohydrate Challenge: Response to Thanopoulou, Karamanos, and Roussi

• Michelle Petrou,
• Marialena Gregoriades,
• and Vassilios Vassiliou

Role of Simvastatin as an Immunomodulator in Type 2 Diabetes: Response to Lopes-Virella et al.

• Dario Iafusco,
• Angela Zanfardino,
• Lucia D’Alessandro,
• and Francesco Prisco

Improper Insulin Compliance May Lead to Hepatomegaly and Elevated Hepatic Enzymes in Type 1 Diabetic Patients: Response to Yu and Howard

• Robert Eugene Hoyt

Peripheral Arterial Disease in People With Diabetes: Response to consensus statement

• Peter Sheehan

Peripheral Arterial Disease in People With Diabetes: Response to Hoyt

• Tom A. Elasy and
• Marie Griffin

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: a consensus statement from the American Heart Association and American Diabetes Association: Response to Nesto

• Richard W. Nesto

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: a consensus statement from the American Heart Association and American Diabetes Association: Response to Elasy and Griffin

Erratum